Vaccination with AstraZeneca, suspended for another three weeks in Denmark. The Copenhagen government does not rule out the connection with the formation of thrombosis

Denmark has decided to extend the AstraZeneca-Oxford serum vaccination by another three weeks. Although the European Medicines Agency (EMA) recommends the use of the vaccine, the Danish government has not explored the link between the vaccine and blood clots.

Denmark has decided to extend the AstraZeneca-Oxford serum vaccination by another three weeks. Although the European Medicines Agency (EMA) recommends the use of the vaccine, the Danish government has not exploded the link between the vaccine and blood clots.

"Today, we have decided today to extend the suspension for another three weeks," Søren Brostrøm, director of the Danish Health Authority, told a news conference.

Denmark was the first country to suspend the use of the AstraZeneca vaccine in mid-March, a decision followed by several countries, mainly Europe.

"We have discussed this with internal experts, who still believe that concerns remain," Brostrøm continued, according to The Local.

The Nordic countries are in no hurry to resume vaccinations with AstraZeneca

The EU Medicines Regulator, EMA, announced last week that the vaccine is "safe and effective", that it is not linked to the risk of blood clots, but that it cannot "definitively rule out" its role in coagulation disorders.

Following this announcement, many European countries have resumed vaccinations with AstraZeneca, while the Nordic countries have maintained their decision to suspend, pending further checks.

Finland and Iceland resumed vaccinations this week, but only for seniors. Sweden is due to announce its decision on Thursday, and a decision is expected in Norway on Friday.

Denmark, a country of 5.8 million people, recorded a total of 227,894 cases of Covid-19 and 2,405 associated deaths. 

More about "Am discutat acest lucru cu experți interni, care încă mai cred că îngrijorările rămân", a continuat Brostrøm, potrivit The Local. Ţările nordice nu se grăbesc să reia vaccinările cu AstraZeneca Regulatorul UE privind medicamentele, EMA, a anunțat săptămâna trecută că vaccinul este „sigur și eficient”, că nu este legat de riscul formării cheagurilor de sânge, dar că nu poate „exclude definitiv” rolul său în tulbărările de coagulare. După acest anunț, numeroase state europene au reluat vaccinările cu AstaZeneca, în timp ce ţările nordice și-au menținut decizia de suspendare, în așteptarea unor verificări suplimentare. Finlanda și Islanda au reluat vaccinările în această săptămână, dar numai pentru seniori. Suedia trebuie să-și anunțe decizia joi, iar vineri se aşteaptă o hotărâre în Norvegia. Danemarca, o țară de 5,8 milioane de persoane, a înregistrat un total de 227.894 de cazuri de Covid-19 și 2.405 de decese asociate.